Trading in Xspray Pharma’s shares commences today on Nasdaq Stockholm
STOCKHOLM – March 27, 2020. Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) announces today the commencement of trading in the company’s shares on Nasdaq Stockholm's main market.“We are very excited about the move to the main market. This is a natural step as we approach a new phase in the company's development and move towards commercialization of our first product. Being listed on a regulated market increases our chances to become an interesting investment for more institutional owners and international specialist investors in biotech”, said Per Andersson, CEO of Xspray. Xspray Pharma’s